OTCM
RELV
Market cap2mUSD
Sep 28, Last price
1.65USD
Name
Reliv International Inc
Chart & performance
P/E
—
P/S
0.14
EPS
—
Div yield, %
—
Shrs. gr., 5y
-9.08%
Rev. gr., 5y
-10.42%
Revenues
21m
-2.09%
Net income
-2m
L-19.77%
CFO
-1m
L+80.96%
Dividend
Nov 13, 20130.01 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Reliv' International, Inc. develops, manufactures, and markets proprietary nutritional supplements. The company offers joint health, protein, gluten free, targeted solutions, blood sugar support, cellular health, cognitive functions and focus, cholesterol support, kid’s nutrition, digestive health, discomfort, energy, aging, heart health, hemp, and immune support products. It also provides multivitamins, omega 3s, probiotics, weight management, dairy and soy free, vegetarian, and vegan products. The company offers its products under the fibrestore, Reliv Classic, Innergize!, and LunaRich C brands. It operates in the United States, Canada, Mexico, the United Kingdom, Ireland, Germany, Australia, New Zealand, the Philippines, Malaysia, Singapore, Austria, the Netherlands, and France. The company was founded in 1988 and is headquartered in Chesterfield, Missouri.
Key people
Ryan Montgomery
President, Chief Executive Officer · since 2018
Steven Albright
Chief Financial Officer, Senior Vice President · since 2005
R. Scott Montgomery
President of Operations and International · since 2018
Thomas Pinnock
President of Sales and Marketing · since 2018
Debra Hellweg
Chief Operating Officer, Senior Vice President · since 2018
Senior Vice President, General Counsel, Secretary · since 2013
Kurt Wulff
Senior Vice President - Marketing · since 2018
Jim Lahm
Vice President - Information Technology · since 2018
Steven Hastings
Executive Vice President - Sales and Marketing · since 2013
Carl Hastings
Vice Chairman of the Board, Chief Scientific Officer · since 2007
Robert Montgomery
Chairman of the Board · since 2018
Robert Henry
Independent Director · since 2013
Independent Director · since 2010
Denis St. John
Independent Director · since 2018
Independent Director
Legal address
C/O CORPORATION SERVICE COMPANY
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
136 Chesterfield Industrial Boulevard
Chesterfield, MO 63005
US
Chesterfield, MO 63005
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||